LNP Formulation - High Throughput Screening and Characterization – Automation – Upscaling – Targeting

Who are we?

The Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), launched in December 2023, has a unique mission to harness airway immunity through innovative vaccine research and development to prevent airborne epidemics.

The aim of the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) is to revolutionize and accelerate vaccine development in Denmark by bridging the gap between academic research and industry innovation. NIVI Research Center is a mission-driven academic research center, anchored at the Department of Immunology and Microbiology at the University of Copenhagen. The primary focus of the center is the development of new or improved vaccine candidates against infectious respiratory diseases including tuberculosis, influenza and group A Streptococcus. NIVI Research Center aims...